Jeff Desjardins - Space, Gene Editing, & Signals Gaining Momentum in the 'Exponential Age'

Opto Sessions – Invest in the Next Big Idea

Get OPTO's best content every day by subscribing to our FREE Newsletter: www.cmcmarkets.com/en/opto/newsletter
Welcome back! Today, we have the pleasure of hosting Jeff Desjardins, Editor-in-Chief of Visual Capitalist & author of the 2021 book ‘Signals: The 27 Trends Defining the Future of the Global Economy.’

In this episode, Jeff maps out the trajectory of the 'Exponential Age,' spotlighting the impact of the new space race, the genomics revolution, and the relentless pace of accelerating technology.
We kick off the conversation by exploring the challenges of discerning signals from noise in today's fast-paced world. Jeff shares insights into the key factors fuelling demand for space-related products and services, highlighting major players in global satellite distribution, such as SpaceX. Delving into genomics, he highlights significant milestones, including the recent FDA approval of the first CRISPR cell therapy designed to treat sickle cell disease. Jeff also discusses potential breakthroughs in areas like cancer treatment, where CRISPR's revolutionary capabilities hold immense promise. Finally, he explains the ‘signal range’ and ‘signal-to-noise ratio’ scores assigned to both themes in his book before sharing his take on the next big idea. Enjoy!
Check out this infographic on thematic investing Visual Capitalist created for OPTO.
- Listen to our previous episode featuring Jeff Desjardins:
Apple Podcasts
Spotify
- Listen to our Rocket Lab interview:
Apple Podcasts
Spotify
- Listen to our ARK Invest's Ali Urman interview on the genomic revolution:
Apple Podcasts
Spotify
Check out our daily newsletter: https://www.cmcmarkets.com/en/opto/newsletter

---------
Past performance is not a reliable indicator of future results.
CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment, or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction, or investment strategy is suitable for any specific person.
The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although we are not specifically prevented from dealing before providing this material, we do not seek to take advantage of the material prior to its dissemination.
CMC Markets does not endorse or offer opinions on the trading strategies used by the author. Their trading strategies do not guarantee any return and CMC Markets shall not be held responsible for any loss that you may incur, either directly or indirectly, arising f